Epidermal growth factor receptor and its role in pancreatic cancer treatment mediated by nanoparticles CM Grapa, T Mocan, D Gonciar, C Zdrehus, O Mosteanu, T Pop, L Mocan International journal of nanomedicine, 9693-9706, 2019 | 57 | 2019 |
Liver injury and elevated FIB-4 define a high-risk group in patients with COVID-19 D Crisan, L Avram, C Grapa, A Dragan, D Radulescu, S Crisan, A Grosu, ... Journal of Clinical Medicine 11 (1), 153, 2021 | 24 | 2021 |
Carbon nanotubes-based assays for cancer detection and screening C Bura, T Mocan, C Grapa, L Mocan Pharmaceutics 14 (4), 781, 2022 | 21 | 2022 |
Tetraspanins: physiology, colorectal cancer development, and nanomediated applications S Titu, CM Grapa, T Mocan, O Balacescu, A Irimie Cancers 13 (22), 5662, 2021 | 15 | 2021 |
Digestive Toxicities Secondary to Immune Checkpoint Inhibition Therapy-Reports of Rare Events. A Systematic Review. L Radulescu, D Crisan, C Grapa, D Radulescu Journal of Gastrointestinal & Liver Diseases 30 (4), 2021 | 11 | 2021 |
PD-L1 expression on immune cells, but not on tumor cells, is a favorable prognostic factor for patients with intrahepatic cholangiocarcinoma LP Mocan, R Craciun, C Grapa, CS Melincovici, I Rusu, N Al Hajjar, ... Cancer Immunology, Immunotherapy 72 (4), 1003-1014, 2023 | 10 | 2023 |
Gastrointestinal Manifestations and Treatment Options in Fabry Disease Patients. A Systematic Review. D Radulescu, D Crisan, V Militaru, E Buzdugan, L Stoicescu, A Grosu, ... Journal of Gastrointestinal & Liver Diseases 31 (1), 2022 | 9 | 2022 |
Recent advances in nanoparticle-mediated diagnosis and the treatment of pancreatic cancer A Nedelcu, T Mocan, C Grapa, L Mocan International Journal of Molecular Sciences 22 (15), 8060, 2021 | 9 | 2021 |
Don’t judge a book by its cover: The role of statins in liver cancer N Piekuś-Słomka, LP Mocan, R Shkreli, C Grapă, K Denkiewicz, ... Cancers 15 (20), 5100, 2023 | 6 | 2023 |
Biomarkers in pancreatic cancer as analytic targets for nanomediated imaging and therapy CM Grapa, L Mocan, D Crisan, M Florea, T Mocan Materials 14 (11), 3083, 2021 | 6 | 2021 |
Basic cardiovascular risk assessment in naïve patients with colon cancer L Radulescu, L Avram, E Buzdugan, D Crisan, A Grosu, C Grapa, ... Experimental and Therapeutic Medicine 23 (5), 1-7, 2022 | 3 | 2022 |
Cirrhosis Progression Is Not Associated with Clinically Significant Alterations in Global Hemostasis Assessed by Thromboelastography R Crăciun, A Buliarcă, D Matei, C Grapă, I Nenu, H Ștefănescu, T Mocan, ... Journal of Clinical Medicine 13 (21), 6614, 2024 | 1 | 2024 |
Unveiling novel serum biomarkers in intrahepatic cholangiocarcinoma: a pilot proteomic exploration LP Mocan, C Grapa, R Crăciun, IE Pralea, A Uifălean, AM Soporan, ... Frontiers in Pharmacology 15, 1440985, 2024 | 1 | 2024 |
Unveiling Health Inequalities: Exploring Metabolic Dysfunction in Rural Roma Communities D Crișan, L Avram, C Grapă, A Nemeș, MV Coman, MS Beldean-Galea, ... Healthcare 12 (8), 816, 2024 | 1 | 2024 |
Increased type-I interferon level is associated with liver damage and fibrosis in primary sclerosing cholangitis RJS Salzmann, C Krötz, T Mocan, LP Mocan, C Grapa, S Rottmann, ... Hepatology Communications 8 (3), e0380, 2024 | 1 | 2024 |
Sarcopenia in MASLD—Eat to Beat Steatosis, Move to Prove Strength D Crişan, L Avram, A Morariu-Barb, C Grapa, I Hirişcau, R Crăciun, ... Nutrients 17 (1), 178, 2025 | | 2025 |
The Bleeding Edge: Managing Coagulation and Bleeding Risk in Patients with Cirrhosis Undergoing Interventional Procedures R Crăciun, C Grapă, T Mocan, C Tefas, I Nenu, A Buliarcă, H Ștefănescu, ... Diagnostics 14 (22), 2602, 2024 | | 2024 |
A NOVEL 5-POINT SCORING SYSTEM FOR THE DIFFERENTIATION OF HCC FROM INTRAHEPATIC CCA IN LR-M PATIENTS RJS Salzmann, T Mocan, C Grapa, LP Mocan, B Wang, R Craciun, ... HEPATOLOGY 78, S100-S101, 2023 | | 2023 |
STANDARD COAGULATION CUT-OFFS FOR INTERVENTIONAL PROCEDURES IN CIRRHOSIS-IS THROMBOELASTOGRAPHY RENDERING THEM OBSOLETE? MA Buliarcă, R Crăciun, B Procopeț, H Ștefănescu, I Nenu, C Grapă, ... Journal of Gastrointestinal & Liver Diseases 32, 2023 | | 2023 |
Biomarkers in Pancreatic Cancer as Analytic Targets for Nanomediated Imaging and Therapy. Materials 2021, 14, 3083 CM Grapa, L Mocan, D Crisan, M Florea, T Mocan s Note: MDPI stays neutral with regard to jurisdictional claims in published …, 2021 | | 2021 |